DR PRASH

DR PRASH

DR PRASH

PSYCHEDELIC SCIENCE: RESISTANCE TO THE RENAISSANCE

Richard Nixon signed the Controlled substances Act in 1970 relegating Psychedelic Drugs to the most restrictive classification of psychoactive substances; that was only the beginning of formal restrictions. The last decade has seen a rennaisance in research into psychedelics and increasing curiosity into their therapeutic potential. However, while this rennaissance has gained media attention and made inroads into societal perspectives, the scientific community and politico-legal bodies lag behind in their uptake. The reasons for the resistance are multifactorial and complex while the ramifications, including limiting access to potential therapies as well as perpetuating stigma are potentially damaging.

DR PRASH works in the psychiatry department of a major metropolitan hospital. His primary intellectual and research interest is in the therapeutic use of psychedelics and their potential role in psychotherapy. He sits on the clinical advisory board of The Australian Psychedelic Society and runs the research discussion group Psychonauts Onymous, bringing together individuals professionally or intellectually connected to the psychedelic paradigm. When not pontificating on the topic at talks and conferences, he is actively seeking your money, or that of your philanthropist grandparents, to help get psychedelic research off the ground in Australia.